Cart
sales@molnova.com
3-Acetylindole
CAS No. 703-80-0
3-Acetylindole ( 3-Acetylindole; 3-Acetylindole; Acetyl-3-indole; 3-Acetyl-1H-indole )
Catalog No. M27295 CAS No. 703-80-0
3-Acetylindole can be used as a substituent and a probe to L-tryptophan for Sudlow site II.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 150 | In Stock |
|
| 100MG | 223 | In Stock |
|
| 500MG | 482 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Acetylindole
-
NoteResearch use only, not for human use.
-
Brief Description3-Acetylindole can be used as a substituent and a probe to L-tryptophan for Sudlow site II.
-
Description3-Acetylindole can be used as a substituent and a probe to L-tryptophan for Sudlow site II.
-
Synonyms3-Acetylindole; 3-Acetylindole; Acetyl-3-indole; 3-Acetyl-1H-indole
-
PathwayOthers
-
TargetOther Targets
-
RecptorBacterial; Parasite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number703-80-0
-
Formula Weight159.2
-
Molecular FormulaC10H9NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)c1c[nH]c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.J A Kolmer, et al. CHEMOTHERAPEUTIC STUDIES WITH ETHYLHYDROCUPREINE HYDROCHLORIDE IN EXPERIMENTAL PNEUMOCOCCUS PLEURITIS. J Exp Med. 1921 May 31;33(6):693-711.
molnova catalog
related products
-
Stressin I
Potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki values are 1.5 and 224 nM for CRF1 and CRF2 receptors respectively). Increases ACTH levels and increases faecal pellet output in vivo following i.p. administration.
-
Canertinib
Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo.
-
2,4-Dihydroxy-6-meth...
2,4-Dihydroxy-6-methoxyacetophenone exhibits a moderate antispasmodic activity.
